|
|
Article: New Research Shows Potential Benefit of Growth Hormone For Obesity and Heart Disease, Without Previously Feared Increased Risk of Cancer; Studies to be Presented at ENDO 2003, The 85th Annual Meeting of The Endocrine Society.
- Article from:
- PR Newswire
- Article date:
- June 19, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA -- PHILADELPHIA, June 19 /PRNewswire/ -- Growth hormone (GH) replacement therapy decreases the risk of cancer and heart problems in GH deficient patients and also causes weight loss in normal obese people, according to new research being presented this week at ENDO 2003, the 85th Annual Meeting of The Endocrine Society. The new studies, which will be presented in a press conference on Saturday, June 21 at 11:30 a.m., help to better identify the risks and benefits associated with GH treatment.
Growth hormone is used as replacement therapy in patients with pituitary diseases, which often impact the body's ability to produce growth hormone. Children ...